AccelerateBS Ind (543938)
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹335 |
| Market Cap | ₹125.15 Cr |
| P/E Ratio | 41 |
| ROCE | 22.18% |
| ROE | —% |
| Dividend Yield | 0.57% |
| Profit Growth | 569.23% |
| Debt/Equity | — |
| Sales Growth | 4.01% |
| 52-Week Range | ₹67 — ₹335 |
| Sector | IT - Software |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Let me start with what I see. AccelerateBS is a tiny software consulting firm with a market cap of ₹125 Cr. At ₹335, the stock trades at 41 times earnings. That is not a bargain by any Graham measure. The company earned roughly ₹1 Cr in the latest quarter on sales of ₹3 Cr—a strong 33% net margin. But when I look at the full picture, sales grew only 4.01%, while profit jumped 569.23%. In my experience, when profits leap while sales barely move, I ask whether the margins are sustainable or whether a one-time event flattered the numbers. The 22.18% ROCE is respectable, and the Piotroski F-Score of 7/9 suggests the balance sheet is not deteriorating. But I cannot ignore the lack of book value, ROE, and promoter holding data. As Graham said, 'In the short run the market is a voting machine, but in the long run it is a weighing machine.' Right now the market is voting with a price that has run from ₹67 to ₹335 in 52 weeks. I am being paid a 0.57% dividend while taking all that risk. The PEG ratio of 0.14 assumes the 569% profit growth continues. That seems too optimistic when sales growth is only 4%. I would need to see many more quarters of profitable growth, higher revenue, and better disclosure before I treat this as a compounding machine. At 41 times earnings with a tiny base, the margin of safety is thin. This may become a fine business, but as an investor I want to be paid for uncertainty, not to pay a premium for it.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer